(3-207) Evaluating Immune-Mediated Adverse Reaction Reporting for Durvalumab and Atezolizumab: A Comparison of Prescribing Information and FDA Adverse Event Reporting System (FAERS) Database
Monday, December 8, 2025
12:00 PM - 1:00 PM
Location: Bayside A, Level 1
Pharmacy School: Notre Dame of Maryland University School of Pharmacy Pharmacy School Location: Maryland
Co-Author(s): Ai- Chen (Jane) L. Ho, Vincent Englebert T. Sy-Siong